Thu, December 22, 2022
Wed, December 21, 2022
Tue, December 20, 2022

Raghuram Selvaraju Maintained (VRNA) at Strong Buy with Increased Target to $32 on, Dec 21st, 2022

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Verona Pharma plc" (VRNA) at Strong Buy with Increased Target from $30 to $32 on, Dec 21st, 2022.

Raghuram has made no other calls on VRNA in the last 4 months.



There are 3 other peers that have a rating on VRNA. Out of the 3 peers that are also analyzing VRNA, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Raghuram


  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Increased Target to $28 on, Tuesday, December 20th, 2022
  • Thomas Shrader of "BTIG" Maintained at Strong Buy with Increased Target to $26 on, Tuesday, December 20th, 2022
  • Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $31 on, Friday, August 26th, 2022